AptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024. In the quarter to June 2026, revenue grew 6.26%, EPS fell 18.3%, free cash flow fell 23.1% and total debt rose 66.4%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten.
Follow ATR
AptarGroup, Inc. (ATR) P/E ratio
As of 16 October 2026, AptarGroup, Inc. (ATR) trades at a P/E ratio of 22.2×. Over the past ten years it has ranged from 17.8× (November 2025) to 43.6× (March 2021); the current reading is higher than 13% of that period. That is below the Medical Instruments & Supplies industry median of 33.8× and in line with the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 20.4× | (26.53%) |
| FY2024 | 27.8× | (1.79%) |
| FY2023 | 28.3× | (6.27%) |
| FY2022 | 30.2× | (8.00%) |
| FY2021 | 32.8× | (20.36%) |
| FY2020 | 41.2× | 35.87% |
| FY2019 | 30.3× | 0.65% |
| FY2018 | 30.2× | 22.32% |
| FY2017 | 24.6× | 10.38% |
| FY2016 | 22.3× | (1.95%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 22.4× | 4.85% |
| Mar 2026 | 21.3× | 4.38% |
| Dec 2025 | 20.4× | (2.95%) |
| Sep 2025 | 21.0× | (20.48%) |
| 42 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| BLCO Bausch + Lomb Corporation compare | n/m |
| AVTR Avantor, Inc. compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| COO The Cooper Companies, Inc. compare | 19.8× |
| ATR AptarGroup, Inc. | 22.2× |
| ALGN Align Technology, Inc. compare | 25.6× |
| STVN Stevanato Group S.p.A. compare | 33.8× |
| MMSI Merit Medical Systems, Inc. compare | 36.4× |
| RGEN Repligen Corporation compare | 234× |
| Medical Instruments & Supplies industry median | 33.8× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)